Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

Chris Selley: Here's to the MP who's not afraid to denounce the Liberals' 'national school lunch' program My husband, 73, is ...

In April, J&J completed the acquisition of Intra-Cellular Therapies, which develops neuroscience drugs to treat conditions ...

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

Zentalis Pharmaceuticals, Inc. focuses on developing azenosertib with a pivotal Denali Phase 2 trial underway. Learn more ...

Merck reported positive results from a trial of Winrevair, the heart drug that the company is counting on for much of its ...

As Donald Trump continues to ramp up his immigration raids and slash social programs, one theme is consistent through his ...

A new microrobot system uses magnetic steering and drug-filled capsules to deliver stroke medicine directly to a clot.

After a rapid rise, Eli Lilly needs only an 11% gain to hit $1 trillion in market value. Revenue is expected to rise 26% next ...

Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to ...

Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed scaling back the role of ...